ID
13968
Description
A Clinical Study Testing The Safety and Efficacy of CH5424802/RO5424802 in Patients With ALK Positive Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01588028
Link
https://clinicaltrials.gov/show/NCT01588028
Keywords
Versions (1)
- 3/20/16 3/20/16 -
Uploaded on
March 20, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility ALK-Rearranged Non-Small Cell Lung Cancer NCT01588028
Eligibility ALK-Rearranged Non-Small Cell Lung Cancer NCT01588028
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Therapy
Data type
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C2974289
Description
Brain metastases
Data type
text
Alias
- UMLS CUI [1]
- C0220650
Description
History of cardiac disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0559157
Description
gastrointestinal disorders; abnormalities; study; drug
Data type
boolean
Alias
- UMLS CUI [1]
- C0596599
Description
lactating
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C2828358
Similar models
Eligibility ALK-Rearranged Non-Small Cell Lung Cancer NCT01588028
- StudyEvent: Eligibility
C3888914 (UMLS CUI [1,2])
C2974289 (UMLS CUI [1,2])
C0439559 (UMLS CUI [1,3])
C1709926 (UMLS CUI [1,2])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C2974289 (UMLS CUI [1,2])
C2828358 (UMLS CUI [2])